Curis Raises $80.8 Million in PIPE to Accelerate Emavusertib Development
Curis Inc. raises up to $80.8 M in a private placement to fund its cancer‑therapeutic pipeline, notably the promising drug emavusertib, boosting its capital and growth prospects.
2 minutes to read